| Elizabeth A Ballard, MD | |
|
1200 E. Elizabeth St., Fort Collins, CO 80524-4007 | |
| (970) 267-9510 | |
| (970) 207-9967 |
| Full Name | Elizabeth A Ballard |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1200 E. Elizabeth St., Fort Collins, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336111541 | NPI | - | NPPES |
| 25307266 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 38219 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth A Ballard, MD 1200 E. Elizabeth Street, Fort Collins, CO 80524-4007 Ph: (970) 267-9510 | Elizabeth A Ballard, MD 1200 E. Elizabeth St., Fort Collins, CO 80524-4007 Ph: (970) 267-9510 |
News Archive
Researchers are close to commercializing a new type of medical imaging technology that could diagnose cardiovascular disease by measuring ultrasound signals from molecules exposed to a fast-pulsing laser.
An eight-year Danish study, which involved more than 2.5 million healthy Danes found there was a higher risk of stroke for those taking high doses of ibuprofen, which is in the painkiller Nurofen. The manufacturers of Nurofen, Reckitt Benckiser, have dismissed these reports. The spokesperson for the company said, "it is important to note that the conclusions drawn by the study authors are based on high doses of ibuprofen…The results of this study should not be confused with non-prescription low doses of NSAIDs, such as ibuprofen, which are available over-the-counter and used by millions of people around the world, for short periods of time, every day."
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced today that it is awarding up to four new grants totaling just under $8 million to local organizations working to prevent or reduce chronic homelessness in their communities. These grants are in addition to $81.5 million in grants awarded under this program in September 2009.
Somaxon Pharmaceuticals, Inc. and Paladin Labs Inc. today announced that they have entered into an exclusive collaboration under which Paladin will commercialize Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance in Canada, South America and Africa.
› Verified 7 days ago
Dr. Michael R Hobaugh, MD, PHD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1330 Oakridge Dr., Ste 100, Pediatric Associates Of Northern Colorado, Fort Collins, CO 80525 Phone: 970-484-4871 Fax: 970-482-4927 | |
Julie M. Brockway, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 E Elizabeth St, Fort Collins, CO 80524 Phone: 970-416-6286 Fax: 970-482-2635 | |
Dr. Kathlene Sue Waller, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Hartshorn Health Service, Colorado State University, Fort Collins, CO 80523 Phone: 970-491-7121 Fax: 970-491-0226 | |
Amy Macritchie, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1024 S Lemay Ave, Fort Collins, CO 80524 Phone: 970-495-8282 | |
Sarah Jayne Hathcock, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1635 Blue Spruce Dr, Fort Collins, CO 80524 Phone: 303-697-2583 Fax: 970-494-4050 | |
Kathleen Anne Hannifan, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 E Elizabeth St, The Youth Clinic, Fort Collins, CO 80524 Phone: 979-267-9510 | |
Dr. Richard Rawson Booth, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2001 S. Shields Street, Bldg G, Fort Collins, CO 80526 Phone: 970-484-4871 Fax: 970-482-4927 |